Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) EBT Margin (2016 - 2025)

Nephros (NEPH) has 16 years of EBT Margin data on record, last reported at 7.14% in Q3 2025.

  • For Q3 2025, EBT Margin rose 194.0% year-over-year to 7.14%; the TTM value through Sep 2025 reached 8.53%, up 1525.0%, while the annual FY2024 figure was 0.63%, 1169.0% up from the prior year.
  • EBT Margin reached 7.14% in Q3 2025 per NEPH's latest filing, up from 5.57% in the prior quarter.
  • Across five years, EBT Margin topped out at 11.87% in Q1 2025 and bottomed at 71.89% in Q1 2022.
  • Average EBT Margin over 5 years is 19.7%, with a median of 11.9% recorded in 2023.
  • Peak YoY movement for EBT Margin: crashed -3431bps in 2022, then surged 6391bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 28.16% in 2021, then rose by 4bps to 26.94% in 2022, then rose by 29bps to 19.11% in 2023, then skyrocketed by 149bps to 9.41% in 2024, then fell by -24bps to 7.14% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 7.14% in Q3 2025, 5.57% in Q2 2025, and 11.87% in Q1 2025.